{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:02:37Z","timestamp":1774645357319,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:00:00Z","timestamp":1337299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037569","type":"journal-article","created":{"date-parts":[[2012,5,20]],"date-time":"2012-05-20T07:49:18Z","timestamp":1337500158000},"page":"e37569","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation"],"prefix":"10.1371","volume":"7","author":[{"given":"Xianmei","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Baylink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daila S.","family":"Gridley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-H. William","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.","volume":"291","author":"GL Anderson","year":"2004","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.maturitas.2010.02.008","article-title":"Treatment of osteoporosis with denosumab.","volume":"66","author":"EM Lewiecki","year":"2010","journal-title":"Maturitas"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.","volume":"25","author":"MS Ominsky","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/17453679609155229","article-title":"Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants.","volume":"Suppl 269","author":"JS Wang","year":"1996","journal-title":"Acta Orthop Scand"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jor.1100150222","article-title":"Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits.","volume":"15","author":"K Nakamura","year":"1997","journal-title":"J Orthop Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/endo.136.3.7867582","article-title":"Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats.","volume":"136","author":"T Nakamura","year":"1995","journal-title":"Endocrinology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00198-003-1374-7","article-title":"Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.","volume":"14","author":"NE Lane","year":"2003","journal-title":"Osteoporos Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S8756-3282(03)00118-2","article-title":"Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.","volume":"33","author":"UT Iwaniec","year":"2003","journal-title":"Bone"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S8756-3282(02)00799-8","article-title":"Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats.","volume":"31","author":"RA Power","year":"2002","journal-title":"Bone"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00198-005-1969-2","article-title":"Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.","volume":"16","author":"W Yao","year":"2005","journal-title":"Osteoporos Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.","volume":"105","author":"A Montero","year":"2000","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/jbmr.2003.18.12.2105","article-title":"Both hPTH(1\u201334) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.","volume":"18","author":"NE Lane","year":"2003","journal-title":"J Bone Miner Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.mt.6300258","article-title":"Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal\/trabecular bone formation in mice.","volume":"15","author":"SL Hall","year":"2007","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jgm.1369","article-title":"Stem cell antigen-1+ cell-based bone morphogenetic protein-4 gene transfer strategy in mice failed to promote endosteal bone formation.","volume":"11","author":"SL Hall","year":"2009","journal-title":"J Gene Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/314377a0","article-title":"Specific expression of a foreign beta-globin gene in erythroid cells of transgenic mice.","volume":"314","author":"K Chada","year":"1985","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood-2008-03-077883","article-title":"Erythroblastic islands: niches for erythropoiesis.","volume":"112","author":"JA Chasis","year":"2008","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/mt.2008.259","article-title":"Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.","volume":"17","author":"TI Pestina","year":"2009","journal-title":"Mol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia.","volume":"467","author":"M Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.","volume":"24","author":"E Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.","volume":"17","author":"U Modlich","year":"2009","journal-title":"Mol Ther"},{"key":"ref21","article-title":"Efficient Reprogramming of Human Cord Blood CD34(+) Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone.","author":"X Meng","year":"2011","journal-title":"Mol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dvdy.20323","article-title":"Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development.","volume":"233","author":"KY Choi","year":"2005","journal-title":"Dev Dyn"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0378-4274(92)90205-X","article-title":"Experience with the preclinical assessment of basic fibroblast growth factor (bFGF).","volume":"64\u201365 Spec No","author":"G Mazue","year":"1992","journal-title":"Toxicol Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/8756-3282(94)00049-2","article-title":"Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats.","volume":"16","author":"H Nagai","year":"1995","journal-title":"Bone"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.20041992","article-title":"Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size.","volume":"201","author":"S Stier","year":"2005","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2006-06-028217","article-title":"FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.","volume":"109","author":"T Nakayama","year":"2007","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/endo.143.7.8884","article-title":"Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.","volume":"143","author":"UT Iwaniec","year":"2002","journal-title":"Endocrinology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.","volume":"98","author":"T Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.","volume":"348","author":"KB Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1590\/S0004-27302006000400025","article-title":"Hypophosphatemic rickets and osteomalacia.","volume":"50","author":"H de Menezes Filho","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jbmr.170","article-title":"FGF-23: More than a regulator of renal phosphate handling?","volume":"25","author":"H Juppner","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1634\/stemcells.2006-0742","article-title":"Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species.","volume":"25","author":"XB Zhang","year":"2007","journal-title":"Stem Cells"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/endo.138.10.5425","article-title":"Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow.","volume":"138","author":"I Martin","year":"1997","journal-title":"Endocrinology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(00)00319-7","article-title":"Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1\u20134.","volume":"27","author":"S Walsh","year":"2000","journal-title":"Bone"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jcb.10594","article-title":"Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.","volume":"89","author":"M Baddoo","year":"2003","journal-title":"J Cell Biochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0014-4827(03)00138-1","article-title":"Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2.","volume":"287","author":"G Bianchi","year":"2003","journal-title":"Exp Cell Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI32479","article-title":"Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.","volume":"117","author":"LJ Nissen","year":"2007","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1432-0436.2007.00210.x","article-title":"Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.","volume":"75","author":"CL Chaffer","year":"2007","journal-title":"Differentiation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/gt.2011.65","article-title":"Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.","volume":"18","author":"I Barde","year":"2011","journal-title":"Gene Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.","volume":"19","author":"G Santilli","year":"2011","journal-title":"Mol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.","volume":"61","author":"C Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00467-010-1565-3","article-title":"FGF23 and the parathyroid glands.","volume":"25","author":"J Silver","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.","volume":"285","author":"L Xiao","year":"2010","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.","volume":"25","author":"A Martin","year":"2011","journal-title":"FASEB J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/jcb.21136","article-title":"Modifications of the fibroblast growth factor-2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor-2 protein.","volume":"100","author":"ST Chen","year":"2007","journal-title":"J Cell Biochem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/mthe.2002.0558","article-title":"Design of HIV vectors for efficient gene delivery into human hematopoietic cells.","volume":"5","author":"PY Yam","year":"2002","journal-title":"Mol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1128\/JVI.79.17.10999-11013.2005","article-title":"A Capsid-Modified Helper-Dependent Adenovirus Vector Containing the \u03b2-Globin Locus Control Region Displays a Nonrandom Integration Pattern and Allows Stable, Erythroid-Specific Gene Expression.","volume":"79","author":"H Wang","year":"2005","journal-title":"Journal of Virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/mt.2010.256","article-title":"Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab.","volume":"19","author":"I Beyer","year":"2011","journal-title":"Mol Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S8756-3282(01)00693-7","article-title":"Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H\/HeJ and C57BL\/6J mice.","volume":"30","author":"MH Sheng","year":"2002","journal-title":"Bone"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T18:33:22Z","timestamp":1561746802000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037569"}},"subtitle":[],"editor":[{"given":"Christopher B.","family":"Doering","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,18]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037569","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,18]]}}}